SkinVision gets $7.6M to continue expanding skin cancer app
Mobi Health News
JULY 30, 2018
Amsterdam-based skin cancer screening app SkinVision has raised $7.6 million in new funding from existing investors Leo Pharma and PHS Fund, with additional contributions from undisclosed new backers described by the company as "high net worth impact investors.
Let's personalize your content